Antibodies in the treatment of lymphoma.
Harvey
M L
ML
Cancer Research Campaign, University Medical Oncology, Southampton University Hospitals, UK.
Illidge
T
T
Johnson
P
P
D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D018033:Antibodies, Bispecific / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D006801:Humans; D000922:Immunotoxins / Q000009:adverse effects / Q000627:therapeutic use; D008223:Lymphoma / Q000532:radiotherapy / Q000628:therapy*; D016499:Radioimmunotherapy / Q000009:adverse effects
D000888:Antibodies, Anti-Idiotypic; D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000922:Immunotoxins